In Gram-positive bacteria, tyrosine kinases are split into two proteins, the cytoplasmic tyrosine kinase and a transmembrane adaptor protein. In Streptococcus pneumoniae, this transmembrane adaptor is CpsC, with the C terminus of CpsC critical for interaction and subsequent tyrosine kinase activity of CpsD. Topology predictions suggest that CpsC has two transmembrane domains, with the N and C termini present in the cytoplasm. In order to investigate CpsC topology, we used a chromosomal hemagglutinin (HA)-tagged Cps2C protein in S. pneumoniae strain D39. Incubation of both protoplasts and membranes with carboxypeptidase B (CP-B) resulted in complete degradation of HA-Cps2C in all cases, indicating that the C terminus of Cps2C was likely extracytoplasmic and hence that the protein's topology was not as predicted. Similar results were seen with membranes from S. pneumoniae strain TIGR4, indicating that Cps4C also showed similar topology. A chromosomally encoded fusion of HA-Cps2C and Cps2D was not degraded by CP-B, suggesting that the fusion fixed the C terminus within the cytoplasm. However, capsule synthesis was unaltered by this fusion. Detection of the CpsC C terminus by flow cytometry indicated that it was extracytoplasmic in approximately 30% of cells. Interestingly, a mutant in the protein tyrosine phosphatase CpsB had a significantly greater proportion of positive cells, although this effect was independent of its phosphatase activity. Our data indicate that CpsC possesses a varied topology, with the C terminus flipping across the cytoplasmic membrane, where it interacts with CpsD in order to regulate tyrosine kinase activity.
T he critical importance of bacterial tyrosine phosphorylation to the basic physiology and virulence of a wide range of pathogens is becoming increasingly more recognized (1) . This has led to the investigation of bacterial protein tyrosine phosphatases and tyrosine kinases (BY kinases) as novel targets for the development of antimicrobials (2, 3) . Streptococcus pneumoniae is one such human pathogen for which tyrosine phosphorylation is critical. In the pneumococcus, tyrosine phosphorylation plays an important role in regulation of the biosynthesis of the polysaccharide capsule. The capsule is considered the major virulence factor of the pneumococcus through its ability to act as an antiphagocytic factor (4) , and indeed all isolates causing invasive disease are encapsulated.
In recent times, we have investigated the role of a tyrosine phosphoregulatory system in the regulation of the biosynthesis of the polysaccharide capsule. The three genes responsible for this system are cotranscribed at the 5= end of the capsule locus, with all being essential for the complete encapsulation of the pneumococcus (5) (6) (7) (8) . These three genes are responsible for encoding a protein tyrosine phosphatase (CpsB) (6) that acts to dephosphorylate an autophosphorylating bacterial tyrosine kinase CpsD (BY kinase), along with the polysaccharide copolymerase protein (PCP) CpsC (7) . While in Gram-negative bacteria BY kinases are present as one single protein, in Gram-positive bacteria they are comprised of two separate cotranscribed proteins that are required for kinase activity (7, 9) . In the pneumococcus, this adaptor protein is CpsC. CpsD forms the active tyrosine kinase, possessing the Walker A and B motifs, as well as the tyrosines present at its C terminus, which are transautophosphorylated by another CpsD monomer (9) . However, CpsC is required for this tyrosine kinase activity, likely through its ability to enable the binding of ATP based on studies of the Staphylococcus aureus homologs (9) , and thus absence of CpsC results in a lack of detectable CpsD autophosphorylation (7, 10) .
CpsC is a member of the 2b subfamily of PCPs (11) . In Gramnegative bacteria, PCPs are associated with regulating O-antigen chain length during O-antigen polymerization and synthesis of type 1 capsules and exopolysaccharides (8, 11) . Previous work undertaken in our laboratory has suggested that CpsC is critical for the attachment of capsule to the cell wall (12) , while a number of amino acid substitutions in this large extracytoplasmic loop significantly reduced phosphorylation of the BY kinase CpsD (13) . This suggests that there is a signal that can be transmitted across the cytoplasmic membrane to or from this extracellular loop and affects CpsD BY kinase activity. However, the nature of this signal and its transmission is still unknown.
In this study, we investigated the topology of CpsC to provide insight into the mechanism for CpsC activation of CpsD. Unexpectedly, using a variety of methods, and in two different strains, we discovered that the C terminus of CpsC has varied topology, with it being both intra-and extracytoplasmic. We suggest that this novel CpsC topology may be critical to its ability to regulate CpsD tyrosine kinase activity and thus regulate encapsulation of this major human pathogen.
MATERIALS AND METHODS
Growth media and growth conditions. S. pneumoniae D39 and TIGR4 were grown in Todd-Hewitt broth with 1% Bacto yeast extract (THY) or on blood agar. Broth cultures were grown at 37°C without agitation. Escherichia coli strains were grown in Luria-Bertani (10 g/liter tryptone, 5 g/liter yeast extract, 5 g/liter NaCl) broth or agar, with transformation carried out using CaCl 2 -treated cells. The antibiotics used were as follows: erythromycin (Ery) (for S. pneumoniae), 0.2 g/ml; and ampicillin (Amp), 100 g/ml.
DNA methods. E. coli K-12 DH5␣ was used for all cloning experiments. DNA manipulation, PCR, transformation, and electroporation were performed as previously described (14) . Oligonucleotide sequences are available on request.
Production of StrepTagII-Cps4CD. A fusion protein comprising the last 29 amino acids (aa) of Cps4C (the predicted cytoplasmic region) with the entire Cps4D protein was constructed by overlap extension PCR. First, the coding sequence for the CpsC C terminus without its stop codon was amplified using AS1/AS2, and the coding sequence for the CpsD protein was amplified with AS3/AS4 using DNA from S. pneumoniae TIGR4 as the template. A second round of PCR with AS1/AS4 stitched these products together. This PCR was then digested with KpnI and SacI, the restriction sites for which were included in primers AS1/AS4. This digested PCR product was then ligated into likewise digested pTRIEX6 to generate a StrepTagII-Cps4CD construct. This ligation was then transformed into strain DH5␣ and screened by PCR, with the correct plasmid confirmed by sequencing (pTRIEX6-Cps4CD). pTRIEX6-Cps4CD was isolated and then transformed into E. coli strain Lemo21(DE3) (15) for protein overexpression, yielding strain AS35.
For overexpression, strains were grown at 37°C for 16 h in LB, subcultured 1/20 into fresh broth, and grown for another 2 h to an optical density at 600 nm (OD 600 ) of ϳ0.5. Strep-TagII-Cps4CD expression was then induced by addition of 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) for a further 2 h. The bacteria were pelleted, and the cells were disrupted using a Constant Systems cell disruptor. The soluble recombinant StrepTagII-Cps4CD was then purified using AKTA prime plus (GE Life Sciences) with StrepTrap (GE Healthcare Life Sciences) as per the manufacturer's instruction, resulting in the purification of approximately 2 mg/ml CpsCD. Protein was then supplied to IMVS, Veterinary Services, Gilles Plain, SA, Australia, where polyclonal rabbit serum was produced, designated anti-CpsCD.
Construction of strains D39EHA:CpsC-L11-CpsD and D39CpsB H136A . A strain that comprised Cps2C fused to Cps2D with a linker (L11) based on a previous study using a different pneumococcal serotype (16) was constructed. The initial rounds of PCR amplified cps2C with linker Cps5= ϩ AS 169 and cps2D with linker AS168 ϩ AS159, using D39EHA: Cps2C chromosomal DNA. These products were then combined in a second round of PCR with oligonucleotides Cps5= ϩ AS159. Transformation and selection were performed as described previously (17) , and transformed colonies were screened by PCR and DNA sequencing.
In order to construct a point mutation in CpsB that inactivated its phosphatase activity, we constructed D39CpsB H136A based on a recent study (18) . Originally, a strain (D39cpsJANUS) was constructed with the janus cassette (19) inserted in place of cpsB, cpsC, and cpsD. In order to do this, first the janus cassette was amplified with oligonucleotides AS113 and AS114 along with flanking regions upstream (AS115 ϩ Cps5=) and downstream (AS116 ϩ AS159) of cpsBCD. The three PCRs were then combined in a second round of PCR with Cps5= and AS 159. This was then transformed into streptomycin-resistant strain D39. Oligonucleotides AS262 ϩ AS159 and AS263 ϩ Cps5= were then used to amplify cps2B from S. pneumoniae D39 encoding the relevant change. The PCRs were combined by a second round of PCR using AS159 ϩ Cps5=, and then this PCR was transformed into D39cpsJANUS. The relevant mutation was confirmed by DNA sequencing.
Western immunoblotting. Insoluble fractions, protoplasts, and whole-cell lysates were separated on 12% SDS-PAGE and transferred to Nitrobind (GE Water and Process Technologies). In order to investigate the presence of smaller digested products, insoluble fractions were separated on 16.5% Mini-Protean Tris-tricine gels (Bio-Rad) according to the manufacturer's instruction, prior to Western immunoblotting. Membranes were probed with primary antibody overnight (antihemagglutinin [anti-HA; Sigma-Aldrich number H3663], 1/2,500; anti-CpsCD, 1/1,000; or anti-PY [4G10; Bio X Cell number BE0194]), and after washing, they were incubated with either goat anti-rabbit or goat anti-mouse secondary antibodies (Biomediq DPC) for 2 h. Detection was performed with chemiluminescence blotting substrate (Sigma-Aldrich) as per the manufacturer's instruction. Benchmark prestained molecular weight markers (Life Technologies) were used as molecular size markers. Stripping of Western immunoblots was performed by incubation with Restore Plus Western blot stripping buffer (Thermo Scientific).
Protoplast formation. Pneumococci were grown to an OD 600 of 0.5 in THY at 37°C and washed twice in 300 l phosphate-buffered saline (PBS), followed by a single wash in 250 l of 0.05 mM EDTA, pH 8. Isolation of membrane-containing fractions. S. pneumoniae cultures were harvested at 17,000 ϫ g for 30 min. Pellets were resuspended in 10 ml resuspension buffer (RB) (100 mM Tris-HCl [pH 7.4], 200 mM NaCl, 20% glycerol) with 100 l 100ϫ Protease Arrest (Gbiosciences) and 5 mM EDTA. Bacterial suspensions were lysed at Ͼ1,000 lb/in 2 via a French pressure cell. Cell debris was removed at 20,000 ϫ g for 50 min. Pellets containing bacterial membranes were isolated from the supernatant by ultracentrifugation at 150,000 ϫ g for 1 h. Pellets were then washed 3 times in 50 ml RB before resuspension in ϳ100 l RB, after which total membrane was quantified using the bicinchoninic acid (BCA) protein assay (Pierce).
CP-B accessibility assays. Carboxypeptidase B (CP-B; Sigma-Aldrich) analysis was conducted according to the manufacturer's instructions. In brief, CP-B digestion was conducted in 20 l of 25 mM Tris-HCl (pH 7.65)-200 mM NaCl at 25°C for 1 h. Total bacterial membrane protein (1 mg · ml Ϫ1 ) or 10 l of protoplasts was used in all assays. In order to identify degradation products, the reaction size was increased to 1 ml, and following CP-B digestion, membranes were isolated by ultracentrifugation at 150,000 ϫ g for 1 h and subsequently analyzed by SDS-PAGE and Western immunoblotting. Protoplast CP-B analysis occurred in 40% (wt/ vol) sucrose to prevent cell lysis. CP-B reactions were stopped after 1 h by the addition of 2 l of a 10ϫ Protease Arrest-50 mM EDTA solution. Samples were then analyzed by Western immunoblotting. Cps2C-L11-Cps2D fusion protein was extracted from 8 mg · ml Ϫ1 D39EHA:Cps2C-L11-Cps2D membranes by solubilization in 0.5% (wt/vol) DDM (n-dodecyl-␤-D-maltoside) for 1 h at 25°C. The remaining insoluble membrane and protein were then removed by ultracentrifugation at 150,000 ϫ g for 1 h, before incubation of the solubilized protein with CP-B.
Flow cytometric analysis. Flow cytometric analysis was carried out on bacterial protoplasts as prepared above. Protoplasts were fixed in PBS with 25% (wt/vol) NaCl-3.7% (vol/vol) formaldehyde for 20 min and washed in PBS with 40% (wt/vol) sucrose. The cells were blocked in PBS with 40% (wt/vol) sucrose, 10% (vol/vol) fetal calf serum, and then primary rabbit anti-CpsCD antibody (1/50) for 3 h. Following 3 washes in PBS with 40% (wt/vol) sucrose, protoplasts were incubated with secondary Alexa Fluor 488 nm donkey anti-rabbit (Life Technologies) antibody for 1 h. Following 3 washes in PBS with 40% (wt/vol) sucrose, flow cytometric analysis of the labeled pneumococcal protoplasts (Ն10,000 events) was then performed on the bacterial protoplasts using a BD FACSCanto (Becton Dickinson Biosciences) cell analyzer, with excitation laser at 488 nm, and emission was captured using the fluorescein isothiocyanate (FITC) 530/30 filter. Baseline fluorescence was calibrated using secondary antibody only.
Analysis was performed by FlowJo. Cells were calculated as positive in relation to a negative control that had only the secondary antibody.
Uronic acid assay. The quantitative uronic acid assay was undertaken essentially as described previously (2, 12) . Levels were related back to a standard curve of D-glucuronic acid (Sigma).
RESULTS
Topology predictions of CpsC. While topology investigations of PCP proteins have been undertaken, the PCP 2b subfamily has so far been neglected. The predicted topology of Cps2C is shown in Fig. 1 . To predict this topology, we have analyzed this protein with the topology programs SPOCTOPUS (20) , TOPSCONS (21), TMpred (22) , and Philius (23), all with similar results. Cps2C was predicted to have two transmembrane domains with the N and C termini in the cytoplasm. The large extracytoplasmic loop is thought to contain a series of alternating ␣-helices and ␤-strands (24). We were thus interested to find out if these predictions were accurate and set out to investigate the topology of CpsC.
CP-B cleaves Cps2C and Cps4C in pneumococcal membranes. We initially investigated the topology of Cps2C using CP-B accessibility assays. CP-B is a C-terminal peptidase with a propensity for basic amino acids, of which there are a substantial number at the C-terminal end of CpsC. Previously, this has been used successfully to investigate the topology of related PCP proteins (25) . CP-B was expected to cleave Cps2C until it met the cell membrane. Using this method, we therefore expected that we would be able to determine the orientation and size of the predicted C-terminal cytoplasmic region. In previous work, we constructed a strain that expressed Cps2C fused to an HA tag at its N terminus (13) . We reasoned that this would allow identification of cleavage products, as ␣HA recognizes its epitope at the N terminus of the protein.
We undertook CP-B cleavage assays using membrane fractions of D39EHA:Cps2C. Following incubation with the protease, the fractions were separated on SDS-PAGE, and Western immunoblotting was undertaken, probing with an antibody against the HA tag to detect HA-Cps2C. Using this method, we saw significant degradation of Cps2C by CP-B ( Fig. 2A and B) . However, there was no evidence of smaller degradation products. The predicted transmembrane region should have stopped CP-B cleavage, resulting in degradation products of significant size and enabling estimation of the size of the cytoplasmic C terminus. As the predicted cytoplasmically located C terminus of Cps2C has a predicted molecular mass of 4.6 kDa (Expasy), we would have expected to identify a protein that was approximately 24 kDa. In order to investigate if CP-B was simply degrading all proteins, we separated the proteins from CP-B-treated membranes by SDS-PAGE and stained the proteins with Coomassie brilliant blue (Fig.  2C) . Few proteins showed any obvious degradation, suggesting that the CP-B cleavage of HA-Cps2C detected was not due to a nonspecific degradation of all protein. Thus, this led to the hypothesis that the topology of Cps2C was not as predicted and shown in Fig. 1A .
In an effort to detect smaller degradation products, we increased the reaction size and optimized the Western blotting procedure as described in Materials and Methods. A band of approximately 9 kDa was evident when we digested with CP-B (Fig. 2D) , with its intensity increasing with increasing CP-B concentration. In order to investigate whether CP-B degradation occurred across serotypes, we investigated cleavage of Cps4C from TIGR4. As Cps4C and Cps2C share significant homology (78% identity), they are predicted to have similar topologies. As this strain did not possess an HA-Cps4C, initially, anti-CpsCD, produced as described in Materials and Methods, was used to probe E. coli-expressed StrepTagII-Cps4C in a Western immunoblot, and a band of the expected size was detected, indicating that this antibody recognized S. pneumoniae Cps4C (Fig. 3A) . The only region in common between CpsCD (the protein used to produce the antibody) and Cps4C is epitopes corresponding to the C-terminal 29 aa of Cps4C. Thus, we used this antibody to probe CP-B degradation of Cps4C in S. pneumoniae TIGR4 membranes. Insoluble membrane fractions were used such that the antibody could not recognize Cps4D, which is a soluble cytoplasmic protein and has been shown previously to not be present in membrane fractions (7) . TIGR4 membrane fractions were incubated with CP-B and subsequently analyzed for cleavage by Western immunoblotting, probing with anti-CpsCD. With S. pneumoniae TIGR4 membranes, significant degradation of Cps4C was detected ( Fig. 3B and C), with almost complete degradation seen with 100 g/ml CP-B. Thus, this suggested that these proteins did indeed share similar topology.
Cps2C is cleaved in D39EHA:Cps2C pneumococcal protoplasts. In order to investigate this further, we performed CP-B cleavage on D39EHA:Cps2C protoplasts. Cleavage would be expected to occur only if the C terminus was extracytoplasmic, as the protease should not enter the cell. Interestingly, significant cleavage of Cps2C was also evident here ( Fig. 4A and D) . As a control to ensure that CP-B did not enter the cell, we stripped the Western immunoblot and reprobed with anti-CpsCD, which, while it rec- Significant degradation was seen at 50 and 100 g/ml of CP-B (*, P Ͻ 0.05; ****, P Ͻ 0.0001; 2-tailed unpaired t test).
ognizes CpsC when used at high concentrations, predominantly recognizes CpsD (as seen by the size difference between the bands in Fig. 4A and B) . This showed that CpsD was not cleaved (Fig.  4B) . Additionally, this also showed that there were not a significant proportion of cells lysing during the protoplast process, which would account for the degradation of Cps2C. However, when lysed D39 protoplasts were incubated with CP-B, significant degradation of CpsD was evident (Fig. 4C) . Thus, these data suggested that CP-B could not traverse the protoplast cell membrane and enter the cytoplasm. This suggested that the C terminus of Cps2C was exposed to the external environment.
D39HACpsC-L11-CpsD is not degraded by carboxypeptidase B. Henriques et al. (16) recently showed that fusion of CpsC and CpsD on the chromosome resulted in a strain that was still encapsulated and regained tyrosine kinase activity. We postulated that fusion of CpsC and CpsD would change the topology and localization of CpsC, resulting in its C terminus being fixed within the cytoplasm. Thus, we constructed a fusion on the pneumococcal chromosome linking the two proteins via a linker as previously described by Henriques et al. This strain, D39EHA:Cps2C-L11-Cps2D, produced capsule at a level similar to that of the wild-type D39EHA:Cps2C strain (Fig. 5A) , which confirms previous findings (16) . Furthermore, the strain produced an approximately 52-kDa protein (corresponding to the size of the CpsC ϩ CpsD ϩ L11 ϩ HA tag), which reacted with both anti-HA and anti-CpsCD, and also intensely with anti-PY (4G10), indicative that it was producing an active tyrosine kinase protein, able to autophosphorylate on tyrosines at its C terminus (Fig. 5B) .
In order to investigate CpsC topology in this strain, we incubated both protoplasts and insoluble protein fractions with CP-B. CP-B was unable to cleave Cps2C-L11-Cps2D when it was incubated with either insoluble membrane fractions or protoplasts of D39EHA:Cps2C-L11-Cps2D (Fig. 5C, D, E, and F) . We confirmed that CP-B was able to cleave this Cps2C-L11-CpsD fusion by solubilizing the membrane protein out of the insoluble fraction and then performing the CP-B cleavage (Fig. 5G) . Thus, these results suggested that fusion of CpsC to CpsD altered the topology of CpsC, although it did not alter its activity in promoting capsule biosynthesis.
Flow cytometry analysis. As described above, anti-CpsCD recognizes both the C-terminal region of Cps4C and that of Cps4D. In order to show that it also recognized Cps2C, and specifically its C terminus, we isolated insoluble membrane fractions of D39EHA:Cps2C and D39EHA:CpsC D202⌬ , a strain in which the 28 C-terminal amino acids are deleted (13) . As D39EHA: CpsC D202⌬ expresses substantially less CpsC than D39EHA: Cps2C, we controlled for this by performing a simultaneous Western immunoblot assay with anti-HA. While anti-CpsCD recognized Cps2C in D39EHA:Cps2C, no corresponding band was detected in D39EHA:CpsC D202⌬ (Fig. 6 ). As this assay was performed with denatured protein, it would be highly unlikely that the antibody is not recognizing CpsC in D39EHA: CpsCD202⌬ due to the mutation affecting the overall folding of the protein. Thus, this showed that anti-CpsCD specifically recognizes the C terminus of Cps2C. Therefore, we decided to use this antibody in flow cytometry in order to provide additional evidence that the C terminus of CpsC was exposed to the environment.
Initially, flow cytometry with anti-CpsCD was undertaken on whole-cell pneumococci; however, no signal was detected (data not shown). This was not surprising, as the capsular polysaccharide present on the outside of the cell likely shields the C terminus of Cps2C. Therefore, we made protoplasts and undertook the flow cytometric analysis as described in Materials and Methods. D39 wild-type protoplasts reacted well, with approximately 30% of cells being positive ( Fig. 7A and B) . Conversely, D39cpsBCD⌬ had only a very small proportion of background positive cells (3.3%), which correlated with its lack of Cps2C (Fig. 7B ). While D39cpsD⌬ protoplasts had a significant reduction in positive cells compared to the wild type (9.5%), this was still greater than that detected for D39cpsBCD⌬ protoplasts. Interestingly, D39cpsB⌬ protoplasts showed a significant increase in positive cells. While the lower level of positive D39cpsD⌬ protoplasts could be attributed to a lower level of CpsC as evidenced by the Western immunoblot of insoluble membrane fractions (Fig. 7D) , D39cpsB produced levels of CpsC similar to those of the wild type, thus not explaining the increased exposure of the C terminus to the environment. In order to investigate if this effect was a result of the tyrosine phosphatase activity of CpsB, we constructed a mutant in CpsB (D39CpsB H136A ) lacking tyrosine phosphatase activity (18) . Interestingly, this mutation did not have any significant effect on CpsC exposure, suggesting that CpsB's role in CpsC topology was independent of its phosphatase activity. TIGR4 protoplasts showed higher Cps4C exposure than did D39 protoplasts (Cps2C), although this did not reach statistical significance (Fig. 7B) .
We also investigated the surface exposure of CpsC in D39EHA: Cps2C-L11-Cps2D. D39EHA:Cps2C-L11-Cps2D had only 4% positive cells, significantly fewer than the corresponding wild-type strain (D39EHA:Cps2C) and only slightly more than the background 3.3% positive cells seen in D39cpsBCD⌬ (Fig. 7C) . This provided further strength to the observation from the CP-B assays that the fusion of the proteins results in a protein with greatly reduced surface-exposed CpsC C terminus.
DISCUSSION
CpsC is a major virulence factor of the pneumococcus, crucial via its role in the regulation of the biosynthesis of capsular polysaccharide. For this reason, we set out to investigate its topology and the mechanisms that it may possess to regulate CpsD BY kinase activity. Two complementary methods, CP-B accessibility assays and flow cytometry, provided evidence that CpsC topology was not as originally thought but that the C terminus of the protein could at least at times be found in an extracellular location. We showed that this phenomenon occurs across pneumococcal strains, since when we performed CP-B accessibility assays with insoluble membrane fractions from TIGR4, cleavage was also detected, with almost complete cleavage at 100 g/ml. Flow cytometric analysis also detected significant exposure of the C terminus, with approximately 10% more cells positive for TIGR4 than for D39, thus suggesting that Cps2C and Cps4C likely exhibit similar topologies. The slight difference may be due to the fact that Cps2C and Cps4C belong to two different sequence clans (26) and indicates that the C terminus of Cps4C may be more extracellularly located than Cps2C.
In order to further investigate this finding, we constructed a strain in which Cps2C was fused to Cps2D via a linker (D39EHA: Cps2C-L11-Cps2D). We hypothesized that this fusion would result in a strain that produces CpsC with its C-terminal region fixed in the cytoplasm, resulting in an altered topology compared to the wild type. Indeed, both CP-B accessibility assays (Fig. 5 ) and flow cytometry (Fig. 7) suggested that this was the case.
We know that it is critically important that the C terminus of CpsC interact with CpsD in order for the BY kinase to gain functionality (9, 27) . For this reason, the C terminus of CpsC must at The number of CpsC C-terminal positive cells was determined relative to that in a control with no anti-CpsCD. D39cpsBCD⌬ and D39cpsD⌬ had significantly fewer positive cells than D39 protoplasts. However, D39cpsD⌬ produced significantly more positive cells than D39cpsBCD⌬. D39cpsB⌬ displayed enhanced CpsC C terminus exposure, while a tyrosine phosphatase-deficient mutant (D39CpsB H136A ) showed no difference. (C) Additionally, D39EHA:Cps2C showed a significantly greater number of positivestained cells than D39EHA:Cps2C-L11-Cps2D (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; Student's 2-tailed t test). All results represent Ն3 replicates (except D39CpsB H136A ; n ϭ 2) and display means Ϯ standard errors. (D) Ten micrograms of insoluble membrane fractions of D39, D39cpsD⌬, or D39cpsB⌬ was analyzed for CpsC expression by Western immunoblotting with anti-CpsCD. D39cpsB⌬ had levels of CpsC similar to those of the wild type, while D39cpsD⌬ showed decreased expression. least at times be cytoplasmically located. Thus, we hypothesize that the C terminus of CpsC possesses multiple topologies, with the C termini located at times within the cytoplasm and at other times extracytoplasmically (Fig. 1B) . We cannot exclude both A and B being present and that rapid flipping across the membrane occurs. Examples of a variety of membrane proteins across a wide range of genera that possess multiple topologies can be found in the literature (28, 29) , and therefore such a finding is not necessarily surprising. It is additionally interesting to speculate that this is a novel method to regulate BY kinase CpsD activity and that such a mechanism may be conserved across the majority of Grampositive bacteria, which possess BY kinases that are split into two, such as seen in the pneumococcus.
Fixing of the CpsC C terminus into the cytoplasm of S. pneumoniae by fusion of CpsC with CpsD did not affect capsule regulation, as has previously been reported (16) . This is not particularly surprising, since although we still do not know the detailed mechanism of capsule regulation by this phosphoregulatory system, we do know that cycling between the phosphorylated and nonphosphorylated forms of the BY kinase is critical (27) . In this fusion strain, switching between phosphorylated and nonphosphorylated CpsD would still occur, as the cognate PTP CpsB acts on the kinase. However, a mutant in the PTP CpsB (D39cpsB⌬) showed a significant increase in the surface-exposed CpsC C terminus, even though CpsC expression levels were similar to those of the wild type. While we initially thought that this may have been due to a loss of phosphatase activity, a mutant that still possesses CpsB but does not have phosphatase activity did not alter CpsC exposure. Thus, this suggests that the structural element of CpsB itself is responsible for this effect. Interestingly, a recent study has suggested that CpsB affects capsule regulation via a mechanism independent of its tyrosine phosphatase activity (18) . Further investigation is required to investigate whether CpsB and CpsC specifically interact and whether this may alter CpsC exposure.
It is also important to consider what effects this difference in topology may have on the three-dimensional (3D) structure of the protein. While no structure of CpsC has been reported to date, structures of other members of the PCP family have been completed (30) . In particular, PCP proteins have been shown to form higher-order oligomeric structures (FepE, 9-mer; WzzE, 8-mer [30] ; CapAB, 8-mer [27] ). Thus, CpsC likely also forms higherorder oligomers, and a change in CpsC topology would likely have significant effects on oligomerization, resulting in functional effects. We are currently working toward a greater structural understanding of CpsC.
This study for the first time has described the variable topology of the C terminus of the PCP and BY kinase adaptor protein CpsC. The switch between these states is likely critical for the regulation of the activity of the BY kinase CpsD and subsequent regulation of capsule biosynthesis. With capsule being the major virulence factor of the pneumococcus, a greater understanding of its regulation is critical for us to be able to identify new methods to combat this major human pathogen.
